What is it about?

We investigated the association between fosfomycin and temocillin on 100 clinical isolates of KPC-producing K. pneumoniae. The results demonstrated synergistic activity in 91% of the isolates. Subsequently, we assessed the effect on Galleria mellonella larvae using five genetically different KPC-Kp isolates. The addition of fosfomycin to temocillin increased Galleria mellonella larvae survival from 73 to 97% (+∆ 32%, isolate 1), from 93 to 100% (+∆ 7%, isolate 2), from 63 to 86% (+∆ 36%, isolate 3), from 63 to 90% (+∆ 42%, isolate 4), and from 93 to 97% (+∆ 4%, isolate 10).

Featured Image

Why is it important?

Among the temocillin-resistant KPC-producing K. pneumoniae isolates (24 isolates), the addition of fosfomycin reduced temocillin MIC values below the resistance breakpoint in all isolates except one. Temocillin combined with fosfomycin emerges as a promising combination against KPC-producing K. pneumoniae, warranting further clinical evaluation.

Read the Original

This page is a summary of: Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <em>Klebsiella pneumoniae </em>Clinical Isolates, March 2024, MDPI AG,
DOI: 10.20944/preprints202403.0415.v1.
You can read the full text:

Read

Contributors

The following have contributed to this page